+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Antacids Market by Drug Class (Acid Neutralizers, H2 Antagonist, Promotility Agents), Formulation (Liquid, Powder, Tablet), Indication, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904677
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antacids Market grew from USD 6.85 billion in 2023 to USD 7.24 billion in 2024. It is expected to continue growing at a CAGR of 5.81%, reaching USD 10.18 billion by 2030.

These include conditions such as heartburn, indigestion, and stomach upset, providing relief by increasing the pH balance in the stomach. The antacid products are available in various forms, including tablets, liquids, and powders to relieve symptoms associated with gastroesophageal reflux disease (GERD), heartburn, and peptic ulcers. The rising prevalence of GERD, heartburn, and other gastric ailments globally is driving the need for antacid products. Modern dietary habits and lifestyles contribute to increased incidences of acidity and related disorders, further propelling the demand for antacids. Continuous research and development aimed at enhancing product efficacy and reducing side effects positively impact market growth. However, stringent regulations regarding the approval and marketing of antacid products can delay product launches, hampering market growth. The availability of alternative therapies and treatments for acid-related disorders poses a significant challenge for market growth. Moreover, ongoing research into natural and organic ingredients can effectively relieve acidity and related conditions, creating opportunities for market growth. Ongoing innovation in drug delivery technologies to improve the efficacy and duration of action of antacid products, generating growth potential in the market.

Regional Insights

In the Americas region, the antacids market is driven by a high prevalence of gastroesophageal reflux disease (GERD) and stress-induced gastritis, amongst other digestive disorders. Consumer preferences lean toward fast-acting, flavored, and chewable forms in major countries such as the United States and Canada. The EMEA region presents a diverse landscape for antacids as the EU countries prioritize medically proven, prescription-based treatments due to stringent regulations. The EMEA market is characterized by a strong presence of global pharmaceutical brands and a growing interest in antacids that offer additional health benefits, such as probiotics. The antacids market in the Middle East and Africa is expanding, driven by lifestyle diseases and an increasing preference for self-medication. Moreover, in the APAC region, the burgeoning middle-class population and increased healthcare spending in China and India are expanding the adoption of antacids in the region. The rising aging population in Japan and a strong focus on preventive healthcare bolster the use of antacids in the APAC region. The domestic antacids market in India is propelled by lifestyle changes, increased fast food consumption, and rising awareness of over-the-counter (OTC) remedies.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Antacids Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Growing population suffering from gastroesophageal reflux disease
  • Government initiatives and investments for domestic drug manufacturing worldwide

Market Restraints

  • Availability of home remedies and other alternatives for acidity-related issues

Market Opportunities

  • Development of more instantly effective and long-lasting antacids
  • Easy availability of antacids in the online pharmacy and regulation flexibility for OTC drugs

Market Challenges

  • Drug recall and contamination issues associated with the antacids

Market Segmentation Analysis

  • Drug Class: Increasing preference for acid neutralizers for improved therapeutic action
  • Indication: Expanding need for antacids for the management of gastroesophageal reflux disease for reducing the acid’s ability to damage the esophageal lining.
  • Formulation: Rising preference for liquid antacid due to their already dissolved state, facilitating quicker relief from symptoms
  • Distribution Channel: Growing availability of antacids across retail pharmacies that provide instant access to antacids without the need for a prescription

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Antacids Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Antacids Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

TUMS Teams Up with DraftKings and Desus Nice to Launch TUMS Prop Bites, Allowing Big Game Fans to Go All In on Food for the First Time

TUMS partners with DraftKings to introduce an innovative platform, TUMS Prop Bites. This unique initiative creates awareness about making free food predictions by offering a chance to compare their selections with others nationwide. The brand's antacid tablets and chews are crafted to immediately relieve heartburn. These chewable solutions address symptoms such as heartburn, acid indigestion, sour stomach, and discomfort.

Dexcel Pharma Acquires 8 OTC Brands to Strengthen its Consumer Healthcare Portfolio

Dexcel Pharma Ltd. announced its strategic acquisition of eight reputable over-the-counter (OTC) brands to diversify and strengthen its consumer healthcare offerings. The enhanced portfolio features well-known products such as EarCalm Spray, Sominex for sleep assistance, Wind-Eze as an antacid, Bisodol for indigestion relief, Cymex for cold sore treatment, Liberize for erectile dysfunction, Yeast Vite supplements, and MacKenzies Smelling Salts for catarrh and colds.

Camber Pharmaceuticals Launches Generic Wellbutrin SR

Camber Pharmaceuticals expanded its product line by introducing Famotidine Powder for oral suspension, USP, a treatment developed to address various gastrointestinal conditions. Suitable for adults, this formulation effectively treats active duodenal and gastric ulcers, relieving the symptoms of non-erosive gastroesophageal reflux disease (GERD).

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Antacids Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Antacids Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aero Healthcare AU Pty Ltd, Alcon Industries, Alkem Laboratories Ltd., Allegiant Health, AstraZeneca plc, Bayer AG, Biocon Limited, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited, Camber Pharmaceuticals, Inc., Cipla Limited, Daiichi Sankyo Company Limited, Dexcel Ltd., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Haleon PLC, Imerys S.A., J. B. Chemicals & Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Magmit Pharmaceutical Co., Ltd., Mankind Pharma Ltd., Marksans Pharma, Nestlé S.A., Novartis AG, Perrigo Company plc, Pfizer Inc., Raritan Pharmaceuticals, Inc., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Swiss Chem Healthcare by Swastik Lifesciences, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., The Procter & Gamble Company, Upsher-Smith Laboratories, LLC by Bora Pharmaceuticals, Wonderbelly, and Zoic Pharmaceuticals Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Antacids Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Class- Acid Neutralizers

  • Aluminum Hydroxide
  • Calcium Carbonate
  • Magnesium Hydroxide
  • Sodium Bicarbonate
  • H2 Antagonist
  • Promotility Agents
  • Proton Pump Inhibitor

Formulation

  • Liquid
  • Powder
  • Tablet

Indication

  • Gastroesophageal Reflux Disease
  • Indigestion/Dyspepsia
  • Peptic Ulcer Disease

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing population suffering from gastroesophageal reflux disease
5.1.1.2. Government initiatives and investments for domestic drug manufacturing worldwide
5.1.2. Restraints
5.1.2.1. Availability of home remedies and other alternatives for acidity-related issues
5.1.3. Opportunities
5.1.3.1. Development of more instantly effective and long-lasting antacids
5.1.3.2. Easy availability of antacids in the online pharmacy and regulation flexibility for OTC drugs
5.1.4. Challenges
5.1.4.1. Drug recall and contamination issues associated with the antacids
5.2. Market Segmentation Analysis
5.2.1. Drug Class: Increasing preference for acid neutralizers for improved therapeutic action
5.2.2. Indication: Expanding need for antacids for the management of gastroesophageal reflux disease for reducing the acid’s ability to damage the esophageal lining.
5.2.3. Formulation: Rising preference for liquid antacid due to their already dissolved state, facilitating quicker relief from symptoms
5.2.4. Distribution Channel: Growing availability of antacids across retail pharmacies that provide instant access to antacids without the need for a prescription
5.3. Market Trend Analysis
5.3.1. Rising prevalence of gastroesophageal reflux disease across the Americas creating need for antacids
5.3.2. Government campaigns creating awareness for enhancing digestive health in the Asia-Pacific
5.3.3. Presence of well-established pharmaceutical industry and government support for domestic drug manufacturing in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Antacids Market, by Drug Class
6.1. Introduction
6.2. Acid Neutralizers
6.3. H2 Antagonist
6.4. Promotility Agents
6.5. Proton Pump Inhibitor
7. Antacids Market, by Formulation
7.1. Introduction
7.2. Liquid
7.3. Powder
7.4. Tablet
8. Antacids Market, by Indication
8.1. Introduction
8.2. Gastroesophageal Reflux Disease
8.3. Indigestion/Dyspepsia
8.4. Peptic Ulcer Disease
9. Antacids Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Americas Antacids Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Antacids Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Antacids Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. TUMS Teams Up with DraftKings and Desus Nice to Launch TUMS Prop Bites, Allowing Big Game Fans to Go All In on Food for the First Time
13.3.2. Dexcel Pharma Acquires 8 OTC Brands to Strengthen its Consumer Healthcare Portfolio
13.3.3. Camber Pharmaceuticals Launches Generic Wellbutrin SR
13.3.4. Reckitt Launches Gaviscon Double Action in Tamil Nadu, Helping People with Acidity and Heartburn
13.3.5. Wonderbelly Expands To Over 1,800 Target Stores to be Easily Accessible to a Broader Audience
13.3.6. Upsher-Smith Launches Famotidine For Oral Suspension
13.3.7. Zydus Secures Final Approval from the USFDA for its Esomeprazole Magnesium Product
13.3.8. Wonderbelly Antacid Brings Exclusive Flavor to Target With Launch
13.3.9. Marksans Pharma Gets USFDA Nod for Famotidine Tablets
13.3.10. ENO Expands its Portfolio with Two New Flavors, Jaljeera and Nimbu Masala
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. ANTACIDS MARKET RESEARCH PROCESS
FIGURE 2. ANTACIDS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ANTACIDS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ANTACIDS MARKET DYNAMICS
FIGURE 7. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTACIDS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ANTACIDS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ANTACIDS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. ANTACIDS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ANTACIDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANTACIDS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ANTACIDS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ANTACIDS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ANTACIDS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ANTACIDS MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ANTACIDS MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ANTACIDS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ANTACIDS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ANTACIDS MARKET SIZE, BY SODIUM BICARBONATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ANTACIDS MARKET SIZE, BY SODIUM BICARBONATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ANTACIDS MARKET SIZE, BY H2 ANTAGONIST, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ANTACIDS MARKET SIZE, BY H2 ANTAGONIST, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ANTACIDS MARKET SIZE, BY PROMOTILITY AGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ANTACIDS MARKET SIZE, BY PROMOTILITY AGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ANTACIDS MARKET SIZE, BY PROTON PUMP INHIBITOR, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ANTACIDS MARKET SIZE, BY PROTON PUMP INHIBITOR, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL ANTACIDS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL ANTACIDS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL ANTACIDS MARKET SIZE, BY INDIGESTION/DYSPEPSIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL ANTACIDS MARKET SIZE, BY INDIGESTION/DYSPEPSIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL ANTACIDS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL ANTACIDS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL ANTACIDS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL ANTACIDS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 83. CANADA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 84. CANADA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 85. CANADA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 86. CANADA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 87. CANADA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 88. CANADA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 89. CANADA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 90. CANADA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 91. CANADA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 92. CANADA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 93. MEXICO ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 94. MEXICO ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 95. MEXICO ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 96. MEXICO ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 97. MEXICO ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 98. MEXICO ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 99. MEXICO ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 100. MEXICO ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 101. MEXICO ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 102. MEXICO ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 137. CHINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 138. CHINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 139. CHINA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 140. CHINA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 141. CHINA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 142. CHINA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 143. CHINA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 144. CHINA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 145. CHINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 146. CHINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 147. INDIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 148. INDIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 149. INDIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 150. INDIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 151. INDIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 152. INDIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 153. INDIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 154. INDIA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 155. INDIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 156. INDIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 167. JAPAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 168. JAPAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 169. JAPAN ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 170. JAPAN ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 171. JAPAN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 172. JAPAN ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 173. JAPAN ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 174. JAPAN ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 175. JAPAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 176. JAPAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 227. THAILAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 228. THAILAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 229. THAILAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 230. THAILAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 231. THAILAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 232. THAILAND ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 233. THAILAND ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 234. THAILAND ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 235. THAILAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 236. THAILAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 259. DENMARK ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 260. DENMARK ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 261. DENMARK ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 262. DENMARK ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 263. DENMARK ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 264. DENMARK ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 265. DENMARK ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 266. DENMARK ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 267. DENMARK ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 268. DENMARK ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 269. EGYPT ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 270. EGYPT ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 271. EGYPT ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 272. EGYPT ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 273. EGYPT ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 274. EGYPT ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 275. EGYPT ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. EGYPT ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. EGYPT ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 278. EGYPT ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 279. FINLAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 280. FINLAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 281. FINLAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 282. FINLAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 283. FINLAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 284. FINLAND ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 285. FINLAND ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 286. FINLAND ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 287. FINLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 288. FINLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 289. FRANCE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 290. FRANCE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 291. FRANCE ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 292. FRANCE ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 293. FRANCE ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 294. FRANCE ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 295. FRANCE ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 296. FRANCE ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 297. FRANCE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 298. FRANCE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 299. GERMANY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 300. GERMANY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 301. GERMANY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 302. GERMANY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 303. GERMANY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 304. GERMANY ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 305. GERMANY ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 306. GERMANY ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 307. GERMANY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 308. GERMANY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 319. ITALY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 320. ITALY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 321. ITALY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 322. ITALY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 323. ITALY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 324. ITALY ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 325. ITALY ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 326. ITALY ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 327. ITALY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 328. ITALY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 329. NETHERLANDS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 330. NETHERLANDS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 331. NETHERLANDS ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 332. NETHERLANDS ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 333. NETHERLANDS ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 334. NETHERLANDS ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 335. NETHERLANDS ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 336. NETHERLANDS ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 337. NETHERLANDS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 338. NETHERLANDS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 339. NIGERIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 340. NIGERIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 341. NIGERIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 342. NIGERIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 343. NIGERIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 344. NIGERIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 345. NIGERIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 346. NIGERIA ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 347. NIGERIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 348. NIGERIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 349. NORWAY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 350. NORWAY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 351. NORWAY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 352. NORWAY ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 353. NORWAY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 354. NORWAY ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 355. NORWAY ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 356. NORWAY ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 357. NORWAY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 358. NORWAY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 359. POLAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 360. POLAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 361. POLAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 362. POLAND ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 363. POLAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 364. POLAND ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 365. POLAND ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 366. POLAND ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 367. POLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 368. POLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 369. QATAR ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 370. QATAR ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 371. QATAR ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 372. QATAR ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 373. QATAR ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 374. QATAR ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 375. QATAR ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 376. QATAR ANTACIDS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 377. QATAR ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 378. QATAR ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 379. RUSSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 380. RUSSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 381. RUSSIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2018-2023 (USD MILLION)
TABLE 382. RUSSIA ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2024-2030 (USD MILLION)
TABLE 383. RUSSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 384. RUSSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 385. RUSSIA ANTACIDS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 386. RUSSIA ANTACIDS MARKET SI

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Aero Healthcare AU Pty Ltd
  • Alcon Industries
  • Alkem Laboratories Ltd.
  • Allegiant Health
  • AstraZeneca plc
  • Bayer AG
  • Biocon Limited
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Limited
  • Camber Pharmaceuticals, Inc.
  • Cipla Limited
  • Daiichi Sankyo Company Limited
  • Dexcel Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • GlaxoSmithKline PLC
  • Haleon PLC
  • Imerys S.A.
  • J. B. Chemicals & Pharmaceuticals Limited
  • Johnson & Johnson Services, Inc.
  • Magmit Pharmaceutical Co., Ltd.
  • Mankind Pharma Ltd.
  • Marksans Pharma
  • Nestlé S.A.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Raritan Pharmaceuticals, Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Swiss Chem Healthcare by Swastik Lifesciences
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • The Procter & Gamble Company
  • Upsher-Smith Laboratories, LLC by Bora Pharmaceuticals
  • Wonderbelly
  • Zoic Pharmaceuticals Pvt. Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.18 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal

Related Topics

Related Reports

Antacids Market Report by Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents), Formulation Type (Tablet, Liquid, Powder, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032 - Product Image

Antacids Market Report by Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents), Formulation Type (Tablet, Liquid, Powder, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Antacids Global Market Report 2024 - Product Image

Antacids Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Antacids - Global Strategic Business Report - Product Image

Antacids - Global Strategic Business Report

  • Report
  • 486 Pages
  • Global
From
Global Antacids Market Report by Formulation Type Distribution Channel Drug Class Countries and Company Analysis, 2024-2032 - Product Image

Global Antacids Market Report by Formulation Type Distribution Channel Drug Class Countries and Company Analysis, 2024-2032

  • Report
  • 210 Pages
  • Global
From
Antacids - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Antacids - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From

About the Antacid Market

The Antacid market is a segment of the Over the Counter (OTC) Drugs industry. Antacids are used to treat symptoms of acid reflux, heartburn, and indigestion. They are available in a variety of forms, including tablets, liquids, and chewable gummies. Antacids are generally safe and effective, and can be purchased without a prescription. The Antacid market is highly competitive, with a wide range of products available from both large and small companies. Many of the products are marketed as being fast-acting and long-lasting, and some are formulated to provide additional benefits such as relief from gas and bloating. Some of the companies in the Antacid market include GlaxoSmithKline, Pfizer, Bayer, Johnson & Johnson, Novartis, and Procter & Gamble. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.